Diabetes, Obesity and Metabolism

Cover image for Vol. 15 Issue 10

October 2013

Volume 15, Issue 10

Pages 871–966

  1. REVIEW ARTICLES

    1. Top of page
    2. REVIEW ARTICLES
    3. ORIGINAL ARTICLES
    4. RESEARCH LETTERS
  2. ORIGINAL ARTICLES

    1. Top of page
    2. REVIEW ARTICLES
    3. ORIGINAL ARTICLES
    4. RESEARCH LETTERS
    1. Effects of pioglitazone versus glimepiride exposure on hepatocellular fat content in type 2 diabetes (pages 915–922)

      E. Phielix, A. Brehm, E. Bernroider, M. Krssak, C.-H. Anderwald, M. Krebs, A. I. Schmid, P. Nowotny and M. Roden

      Article first published online: 1 MAY 2013 | DOI: 10.1111/dom.12112

    2. Effect of pioglitazone on body composition and bone density in subjects with prediabetes in the ACT NOW trial (pages 931–937)

      G. A. Bray, S. R. Smith, M. A. Banerji, D. Tripathy, S. C. Clement, T. A. Buchanan, R. R. Henry, A. E. Kitabchi, S. Mudaliar, N. Musi, R. E. Ratner, D. C. Schwenke, F. B. Stentz, P. D. Reaven and R. A. DeFronzo

      Article first published online: 7 MAY 2013 | DOI: 10.1111/dom.12099

  3. RESEARCH LETTERS

    1. Top of page
    2. REVIEW ARTICLES
    3. ORIGINAL ARTICLES
    4. RESEARCH LETTERS
    1. Bone loss in the oestrogen-depleted rat is not exacerbated by sitagliptin, either alone or in combination with a thiazolidinedione (pages 954–957)

      T. Cusick, J. Mu, B. L. Pennypacker, Z. Li, K. R. Scott, X. Shen, J. E. Fisher, R. B. Langdon, D. B. Kimmel, B. B. Zhang and H. Glantschnig

      Article first published online: 1 MAY 2013 | DOI: 10.1111/dom.12109

SEARCH

SEARCH BY CITATION